EQRx, Inc.
EQRX
Cena:
Valuace
70
Růst
0
Zdraví
71
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
0
CALLING ALL EQRX, INC. (EQRX) INVESTORS: CONTACT BRONSTEIN, GEWIRTZ & GROSSMAN, LLC TO CLAIM YOUR LOSSES
26-10-2023
NEW YORK , OCT. 26, 2023 /PRNEWSWIRE/ -- ATTORNEY ADVERTISING--BRONSTEIN, GEWIRTZ & GROSSMAN, LLC I...
Více zde
EQRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF EQRX, INC. - EQRX
06-10-2023
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde
EQRX SHAREHOLDER INVESTIGATION: ROBBINS LLP REMINDS SHAREHOLDERS IT IS INVESTIGATING EQRX, INC. ON BEHALF OF SHAREHOLDERS
27-09-2023
SAN DIEGO--(BUSINESS WIRE)---- $EQRX #CMLIFESCIENCESIIIINC--EQRX, INC. (EQRX) MAY HAVE ENGAGED IN A ...
Více zde
EQRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF EQRX, INC. - EQRX
02-08-2023
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde
SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER EQRX, INC. HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH REVOLUTION MEDICINES
02-08-2023
MILWAUKEE , AUG. 2, 2023 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING EQRX (NASDAQ: EQRX) FOR POSSIBL...
Více zde
EQRX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF EQRX, INC. IS FAIR TO SHAREHOLDERS
01-08-2023
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde
OMNIAB REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
11-05-2023
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINANCIAL RESULTS FO...
Více zde
EQRX, INC. (EQRX) SHAREHOLDER INVESTIGATION: ROBBINS LLP IS INVESTIGATING EQRX, INC. ON BEHALF OF SHAREHOLDERS
21-04-2023
SAN DIEGO--(BUSINESS WIRE)--SHAREHOLDER RIGHTS LAW FIRM ROBBINS LLP IS INVESTIGATING EQRX, INC. (NAS...
Více zde
AI OPPORTUNITIES IN PERSONALISED MEDICINE 2023: DAWN OF THE AI ERA SET TO UNLOCK NEW UNDERSTANDING OF DISEASE PATHOLOGIES - RESEARCHANDMARKETS.COM
04-04-2023
DUBLIN--(BUSINESS WIRE)--THE "AI OPPORTUNITIES IN PERSONALISED MEDICINE" REPORT HAS BEEN ADDED TO RE...
Více zde
OMNIAB REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
30-03-2023
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINANCIAL RESULTS FO...
Více zde
EQRX REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND RECENT CORPORATE PROGRESS
23-02-2023
FOR INVESTORS...
Více zde
EQRX TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
03-01-2023
CAMBRIDGE, MASS., JAN. 03, 2023 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
EQRX ANNOUNCES ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION BY THE UK'S MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY FOR SUGEMALIMAB IN METASTATIC NON-SMALL CELL LUNG CANCER
19-12-2022
CAMBRIDGE, MASS., DEC. 19, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
BE BIOPHARMA APPOINTS JOHN MAYFIELD, PH.D., AS CHIEF BUSINESS OFFICER
08-12-2022
CAMBRIDGE, MASS.--(BUSINESS WIRE)--BE BIOPHARMA (“BE BIO”) TODAY ANNOUNCED THE APPOINTMENT OF JO...
Více zde
EQRX ANNOUNCES ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION BY THE EUROPEAN MEDICINES AGENCY FOR AUMOLERTINIB IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER
02-12-2022
CAMBRIDGE, MASS., DEC. 02, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
EQRX TO PARTICIPATE IN THE JEFFERIES 2022 LONDON HEALTHCARE CONFERENCE
07-11-2022
CAMBRIDGE, MASS., NOV. 07, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
EQRX TO HOLD THIRD QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, NOVEMBER 10, 2022
28-10-2022
CAMBRIDGE, MASS., OCT. 28, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
EQRX REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND RECENT CORPORATE PROGRESS
11-08-2022
CAMBRIDGE, MASS., AUG. 11, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
LIGAND REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
08-08-2022
EMERYVILLE, CALIF.--(BUSINESS WIRE)--LIGAND PHARMACEUTICALS INCORPORATED (NASDAQ: LGND) TODAY REPORT...
Více zde
EQRX ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF FINAL PROGRESSION-FREE SURVIVAL RESULTS FROM PHASE 3 TRIAL OF SUGEMALIMAB IN STAGE III NON-SMALL CELL LUNG CANCER AT IASLC 2022 WORLD CONFERENCE ON LUNG CANCER
07-08-2022
CAMBRIDGE, MASS., AUG. 07, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
IDRX LAUNCHES WITH $122 MILLION SERIES A FINANCING TO TREAT CANCER WITH PURPOSE-BUILT PRECISION COMBINATION THERAPIES
02-08-2022
PLYMOUTH, MASS.--(BUSINESS WIRE)--IDRX, INC., A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY DEDICATED T...
Více zde
AURIGENE DISCOVERY TECHNOLOGIES LIMITED宣佈與EQRX建立藥物發現、開發和商業化合作夥伴關係
06-07-2022
印度班加羅爾--(BUSINESS WIRE)--(美國商業資訊)--雙方的合作將結合AURIGENE的小分...
Více zde
AURIGENE DISCOVERY TECHNOLOGIES LIMITED宣布与EQRX建立药物发现、开发和商业化合作伙伴关系
06-07-2022
印度班加罗尔--(BUSINESS WIRE)--(美国商业资讯)--双方的合作将AURIGENE的小分子药...
Více zde
オーリジーン・ディスカバリー・テクノロジーズ・リミテッドがEQRXと創薬・開発・商業化で提携した発表
05-07-2022
印ベンガルール--(BUSINESS WIRE)--（ビジネスワイヤ） -- この連携では、オー...
Více zde
EQRX ANNOUNCES ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION BY THE UK'S MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY FOR AUMOLERTINIB IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER
14-06-2022
CAMBRIDGE, MASS., JUNE 14, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMAC...
Více zde
EQRX ANNOUNCES NEW DATA FOR LEAD ONCOLOGY PROGRAMS IN NON-SMALL CELL LUNG CANCER AND RARE FORM OF NON-HODGKIN LYMPHOMA AT ASCO 2022
26-05-2022
CAMBRIDGE, MASS., MAY 26, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMACE...
Více zde
EQRX REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND RECENT CORPORATE PROGRESS
13-05-2022
CAMBRIDGE, MASS., MAY 13, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMACE...
Více zde
EQRX TO HOLD FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON FRIDAY, MAY 13, 2022
29-04-2022
CAMBRIDGE, MASS., APRIL 29, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMA...
Více zde
EQRX ANNOUNCES NEW DATA ON LEAD ONCOLOGY PROGRAMS TO BE PRESENTED AT 2022 ASCO ANNUAL MEETING
27-04-2022
CAMBRIDGE, MASS., APRIL 27, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMA...
Více zde
EQRX REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND RECENT CORPORATE PROGRESS
23-03-2022
CAMBRIDGE, MASS., MARCH 23, 2022 (GLOBE NEWSWIRE) -- EQRX, INC. (NASDAQ: EQRX), A NEW TYPE OF PHARMA...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2023-11-09 00:00:00 | 8-K |  | Stáhnout |
| 2023-11-08 23:00:00 | 8-K | | Stáhnout |
| 2023-11-06 00:00:00 | 10-Q | | Stáhnout |
| 2023-11-05 23:00:00 | 10-Q | | Stáhnout |
| 2023-11-01 00:00:00 | 8-K | | Stáhnout |
| 2023-10-31 23:00:00 | 8-K | | Stáhnout |
| 2023-08-08 01:00:00 | 10-Q | | Stáhnout |
| 2023-08-08 00:00:00 | 10-Q | | Stáhnout |
| 2023-08-03 01:00:00 | 8-K | | Stáhnout |
| 2023-08-03 00:00:00 | 8-K | | Stáhnout |
| 2023-08-01 01:00:00 | 8-K | | Stáhnout |
| 2023-08-01 00:00:00 | 8-K | | Stáhnout |
| 2023-05-08 01:00:00 | 8-K | | Stáhnout |
| 2023-05-08 01:00:00 | 10-Q | | Stáhnout |
| 2023-05-08 00:00:00 | 8-K | | Stáhnout |
| 2023-05-08 00:00:00 | 10-Q | | Stáhnout |
| 2023-03-13 00:00:00 | 8-K | | Stáhnout |
| 2023-03-12 23:00:00 | 8-K | | Stáhnout |
| 2023-02-23 00:00:00 | 8-K | | Stáhnout |
| 2023-02-23 00:00:00 | 10-K | | Stáhnout |
| 2023-02-22 23:00:00 | 8-K | | Stáhnout |
| 2023-02-22 23:00:00 | 10-K | | Stáhnout |
| 2023-01-11 00:00:00 | 8-K | | Stáhnout |
| 2023-01-10 23:00:00 | 8-K | | Stáhnout |
| 2022-11-25 00:00:00 | 8-K | | Stáhnout |
| 2022-11-24 23:00:00 | 8-K | | Stáhnout |
| 2022-11-10 00:00:00 | 8-K | | Stáhnout |
| 2022-11-10 00:00:00 | 10-Q | | Stáhnout |
| 2022-11-09 23:00:00 | 8-K | | Stáhnout |
| 2022-11-09 23:00:00 | 10-Q | | Stáhnout |
| 2022-10-03 01:00:00 | 8-K | | Stáhnout |
| 2022-10-03 00:00:00 | 8-K | | Stáhnout |
| 2022-08-11 01:00:00 | 8-K | | Stáhnout |
| 2022-08-11 01:00:00 | 10-Q | | Stáhnout |
| 2022-08-11 00:00:00 | 8-K | | Stáhnout |
| 2022-08-11 00:00:00 | 10-Q | | Stáhnout |
| 2022-07-15 01:00:00 | 8-K | | Stáhnout |
| 2022-07-15 00:00:00 | 8-K | | Stáhnout |
| 2022-05-13 01:00:00 | 8-K | | Stáhnout |
| 2022-05-13 01:00:00 | 10-Q | | Stáhnout |
| 2022-05-13 00:00:00 | 8-K | | Stáhnout |
| 2022-05-13 00:00:00 | 10-Q | | Stáhnout |
| 2022-03-23 00:00:00 | 8-K | | Stáhnout |
| 2022-03-23 00:00:00 | 10-K | | Stáhnout |
| 2022-03-22 23:00:00 | 8-K | | Stáhnout |
| 2022-03-22 23:00:00 | 10-K | | Stáhnout |
| 2022-01-10 00:00:00 | 8-K | | Stáhnout |
| 2022-01-09 23:00:00 | 8-K | | Stáhnout |
| 2021-12-20 00:00:00 | 8-K | | Stáhnout |
| 2021-12-19 23:00:00 | 8-K | | Stáhnout |
| 2021-12-17 00:00:00 | 8-K | | Stáhnout |
| 2021-12-16 23:00:00 | 8-K | | Stáhnout |
| 2021-11-23 00:00:00 | 8-K | | Stáhnout |
| 2021-11-22 23:00:00 | 8-K | | Stáhnout |
| 2021-11-15 00:00:00 | 10-Q | | Stáhnout |
| 2021-11-14 23:00:00 | 10-Q | | Stáhnout |
| 2021-10-29 01:00:00 | 8-K | | Stáhnout |
| 2021-10-29 00:00:00 | 8-K | | Stáhnout |
| 2021-08-16 01:00:00 | 10-Q | | Stáhnout |
| 2021-08-16 00:00:00 | 10-Q | | Stáhnout |
| 2021-08-06 01:00:00 | 8-K | | Stáhnout |
| 2021-08-06 00:00:00 | 8-K | | Stáhnout |
| 2021-08-03 01:00:00 | 8-K | | Stáhnout |
| 2021-08-03 00:00:00 | 8-K | | Stáhnout |
| 2021-06-02 01:00:00 | 8-K | | Stáhnout |
| 2021-06-02 00:00:00 | 8-K | | Stáhnout |
| 2021-05-27 01:00:00 | 8-K | | Stáhnout |
| 2021-05-27 00:00:00 | 8-K | | Stáhnout |
| 2021-05-26 01:00:00 | 10-Q | | Stáhnout |
| 2021-05-26 00:00:00 | 10-Q | | Stáhnout |
| 2021-04-09 01:00:00 | 8-K | | Stáhnout |
| 2021-04-09 00:00:00 | 8-K | | Stáhnout |
